Market revenue in 2023 | USD 15.1 million |
Market revenue in 2030 | USD 33.6 million |
Growth rate | 12.1% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 80.79% in 2023. Horizon Databook has segmented the Latin America mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
Technological developments are expected to contribute to market growth. Increasing government expenditure on R&D, presence of skilled healthcare professionals, and rising focus of multinational pharmaceutical companies on miRNA sequencing products & services are expected to drive the market growth over the forecast period.
In addition, increasing investment initiatives by various local and foreign organizations in the Latin American region will aid growth. For instance, the Latin American Venture Capital Association is a notfor-profit membership organization involved in supporting growth of private capital in Latin America and the Caribbean.
Moreover, Latin America Investment Facility (LAIF) is a European Union's facility to mobilize funds for developing projects by combining EU grants with financial resources from European as well as regional financial institutions, the private sector, & the governments.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America mirna sequencing and assay market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account